Improving Transparency to Lower Drug Costs Act of 2021
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Improving Transparency to Lower Drug Costs Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 3682: Improving Transparency to Lower Drug Costs Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-3682/
"H.R. 3682: Improving Transparency to Lower Drug Costs Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-3682/.
H.R. 3682, 117th Cong. (2026), https://openamerica.io/bill/117-HR-3682/.
[H.R. 3682: Improving Transparency to Lower Drug Costs Act of 2021](https://openamerica.io/bill/117-HR-3682/)